Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.58
-3.50 (-23.21%)
At close: Oct 29, 2025, 4:00 PM EDT
11.64
+0.06 (0.52%)
After-hours: Oct 29, 2025, 7:49 PM EDT
Avantor Revenue
Avantor had revenue of $1.62B in the quarter ending September 30, 2025, a decrease of -5.28%. This brings the company's revenue in the last twelve months to $6.58B, down -3.59% year-over-year. In the year 2024, Avantor had annual revenue of $6.78B, down -2.64%.
Revenue (ttm)
$6.58B
Revenue Growth
-3.59%
P/S Ratio
1.20
Revenue / Employee
$487,052
Employees
13,500
Market Cap
7.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.78B | -183.60M | -2.64% |
| Dec 31, 2023 | 6.97B | -545.20M | -7.26% |
| Dec 31, 2022 | 7.51B | 126.30M | 1.71% |
| Dec 31, 2021 | 7.39B | 992.50M | 15.52% |
| Dec 31, 2020 | 6.39B | 353.30M | 5.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
AVTR News
- 5 hours ago - Avantor, Inc. (AVTR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 hours ago - Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback - Benzinga
- 14 hours ago - Avantor® Reports Third Quarter 2025 Results - PRNewsWire
- 6 days ago - Avantor® Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables - PRNewsWire
- 14 days ago - Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology - PRNewsWire
- 16 days ago - Avantor® Announces Board Chairman Transition - PRNewsWire
- 26 days ago - Avantor® Appoints Gregory T. Lucier to its Board of Directors - PRNewsWire
- 4 weeks ago - Avantor® to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025 - PRNewsWire